Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment

7Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Coffee is associated with decreased breast cancer risk, but the impact of body mass index (BMI) in combination with coffee consumption on prognosis is unclear. The suppressive effect of coffee constituents on the insulin-like growth factor receptor 1 (IGF1R) levels in breast cancer cells may play a role. The aim was to investigate the prognostic impact of coffee consumption and possible associations with tumor-specific IGF1R protein expression and BMI in a population-based cohort in Sweden, comprising 1,014 primary breast cancer patients without pretreatment enrolled 2002-2012 and followed for up to 13 years. Patients with higher coffee consumption had lower tumor IGF1R levels (P = 0.025), but only among the normal-weight patients (P = 0.005). Coffee did not impact the recurrence-risk overall. However, tamoxifen-treated patients with ER+ tumors drinking ≥ 2 cups of coffee/day had lower recurrence-risk [adjusted HR (HRadj) 0.57, 95% CI, 0.34-0.97] compared with patients with lower intake, although only among normal-weight patients (HRadj 0.37, 95% CI: 0.17-0.78; Pinteraction = 0.039). Similarly, coffee consumption ≥ 2 cups/day was associated with significantly lower recurrence-risk among the 640 radiotherapy-treated patients irrespective of BMI (HRadj 0.59, 95% CI 0.36-0.98) and in the 296 normal-weight patients (HRadj 0.36, 95% CI 0.17-0.76) but not in the 329 overweight or obese patients (HRadj 0.88, 95% CI 0.42-1.82) although the interaction was not significant (Pinteraction = 0.093). In conclusion, coffee consumption was negatively associated with tumor-specific IGF1R levels only among normal-weight patients. Though, IGF1R did not explain the association between coffee intake and improved prognosis among normal-weight tamoxifen- or radiotherapy-treated patients. Studies of IGF1R-targeting therapies may benefit from taking BMI and coffee consumption into account.

References Powered by Scopus

The insulin and insulin-like growth factor receptor family in neoplasia: An update

939Citations
N/AReaders
Get full text

REporting recommendations for tumor MARKer prognostic studies (REMARK)

450Citations
N/AReaders
Get full text

Coffee, Caffeine, and Health Outcomes: An Umbrella Review

386Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Coffee consumption and breast cancer risk: a narrative review in the general population and in different subtypes of breast cancer

10Citations
N/AReaders
Get full text

Does coffee, tea and caffeine consumption reduce the risk of incident breast cancer? A systematic review and network meta-analysis

6Citations
N/AReaders
Get full text

Inter-Individual Variation in Cancer and Cardiometabolic Health Outcomes in Response to Coffee Consumption: A Critical Review

6Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Björner, S., Rosendahl, A. H., Tryggvadottir, H., Simonsson, M., Jirström, K., Borgquist, S., … Jernström, H. (2018). Coffee is associated with lower breast tumor insulin-like growth factor receptor 1 levels in normal-weight patients and improved prognosis following tamoxifen or radiotherapy treatment. Frontiers in Endocrinology, 9(JUN). https://doi.org/10.3389/fendo.2018.00306

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

100%

Readers' Discipline

Tooltip

Medicine and Dentistry 7

58%

Agricultural and Biological Sciences 2

17%

Biochemistry, Genetics and Molecular Bi... 2

17%

Pharmacology, Toxicology and Pharmaceut... 1

8%

Article Metrics

Tooltip
Social Media
Shares, Likes & Comments: 102

Save time finding and organizing research with Mendeley

Sign up for free